Skip to main content

Alto Neuroscience, Inc.

ANRO
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001999480

In the last 90 days, Alto Neuroscience, Inc. insiders filed 0 open-market purchases and 2 sales; 132 institutions reported holding it in 13F filings for Q3 2026, worth $991.9M in total; no superinvestor holds it.

Holders of 5% or more of ANRO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alto Neuroscience, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ANRO
HolderLatest formStakeChangeFirst filedLatest filingFiling
Perceptive Advisors LLC13G/A9.99%4.18M shares0.00 ppfrom 9.99%Oct 10, 20253 filingsAug 14, 2026SEC
Commodore Capital LP13G/A9.90%3.59M shares0.00 ppfrom 9.90%Oct 27, 20253 filingsMay 15, 2026SEC
Sirenia Capital Management LP13G/A6.20%2.22M shares−1.70 ppfrom 7.90%May 15, 20262 filingsAug 14, 2026SEC
BlackRock, Inc.13G6.00%2.10M shares+3.90 ppfrom 2.10%Oct 21, 20244 filingsJul 27, 2026SEC
Armistice Capital, LLC13G/A6.00%1.62M shares0.00 ppfrom 6.00%Aug 14, 20252 filingsFeb 17, 2026SEC
EcoR1 Capital, LLC13G5.80%2.23M sharesNewJul 20, 20261 filingJul 20, 2026SEC
Vanguard Capital Management LLC13G5.02%1.97M sharesNewOct 30, 20261 filingOct 30, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

35 Schedule 13D and 13G filings on Alto Neuroscience, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ANRO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 30, 202611:01 AM ETVanguard Capital Management LLC13G5.02%1.97M sharesNewSep 30, 2026SEC
Aug 14, 20265:18 PM ETPerceptive Advisors LLCand 2 others13G/A9.99%4.18M shares0.00 ppfrom 9.99%Jun 30, 2026SEC
Aug 14, 20264:06 PM ETVestal Point Capital, LPand 1 other13G/A2.20%785.0K shares−4.30 ppfrom 6.50%Below 5%Jun 30, 2026SEC
Aug 14, 20268:30 AM ETSirenia Capital Management LPand 1 other13G/A6.20%2.22M shares−1.70 ppfrom 7.90%Jun 30, 2026SEC
Jul 27, 20264:25 PM ETBlackRock, Inc.13G6.00%2.10M shares+3.90 ppfrom 2.10%Jun 30, 2026SEC
Jul 20, 20265:10 PM ETEcoR1 Capital, LLCand 2 others13G5.80%2.23M sharesNewJul 13, 2026SEC
May 15, 20265:05 PM ETVestal Point Capital, LPand 1 other13G/A6.50%2.06M shares−1.50 ppfrom 8.00%Mar 31, 2026SEC
May 15, 20264:11 PM ETPoint72 Asset Management, L.P.and 5 others13G/A3.70%1.17M shares−5.20 ppfrom 8.90%Below 5%Mar 31, 2026SEC
May 15, 20264:07 PM ETCommodore Capital LPand 3 others13G/A9.90%3.59M shares0.00 ppfrom 9.90%Mar 31, 2026SEC
May 15, 20268:07 AM ETSirenia Capital Management LPand 1 other13G7.90%2.59M sharesNewMar 31, 2026SEC
Feb 18, 20264:46 PM ETArmistice Capital, LLCand 1 other13G/A4.94%1.54M shares−0.97 ppfrom 5.91%Below 5%Dec 31, 2025SEC
Feb 17, 20269:53 PM ETArmistice Capital, LLCand 1 other13G/A6.00%1.62M shares0.00 ppfrom 6.00%Dec 31, 2025SEC
Feb 17, 20264:40 PM ETK2 HealthVentures Equity Trust LLCand 2 others13G/A2.40%789.0K shares−3.20 ppfrom 5.60%Below 5%Dec 31, 2025SEC
Feb 17, 20264:30 PM ETPoint72 Asset Management, L.P.and 5 others13G/A8.90%2.82M shares+1.90 ppfrom 7.00%Dec 31, 2025SEC
Feb 17, 20264:13 PM ETCommodore Capital LPand 3 others13G/A9.90%3.25M shares+0.10 ppfrom 9.80%Dec 31, 2025SEC
Feb 17, 20264:05 PM ETVestal Point Capital, LPand 1 other13G8.00%2.48M sharesNewDec 31, 2025SEC
Feb 17, 20264:00 PM ETPerceptive Advisors LLCand 2 others13G/A9.99%3.25M shares+2.69 ppfrom 7.30%Dec 31, 2025SEC
Oct 27, 20254:02 PM ETCommodore Capital LPand 3 others13G9.80%3.19M sharesNewOct 20, 2025SEC
Oct 10, 202512:50 PM ETPerceptive Advisors LLCand 2 others13G7.30%1.99M sharesNewOct 3, 2025SEC
Aug 14, 20259:36 PM ETArmistice Capital, LLCand 1 other13G/A6.00%1.62M shares–Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A2.10%561.4K shares–Below 5%Jun 30, 2025SEC
May 15, 20254:26 PM ETPoint72 Asset Management, L.P.and 5 others13G/A7.00%1.91M shares−1.80 ppfrom 8.80%Mar 31, 2025SEC
May 15, 20253:19 PM ETK2 HealthVentures Equity Trust LLCand 2 others13G5.60%1.62M sharesNewJan 13, 2025SEC
May 15, 20253:05 PM ETArmistice Capital, LLCand 1 other13G5.91%1.60M sharesNewMar 31, 2025SEC
Feb 14, 20256:26 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 14, 20254:05 PM ETPoint72 Asset Management, L.P.and 5 others13G/A8.80%2.36M shares–Dec 31, 2024SEC
Feb 12, 20259:16 AM ETFMR LLCand 1 other13G/A4.70%1.27M shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Etkin Amit13GOld format–New–SEC
Nov 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Nov 12, 2024FMR LLC13GOld format–New–SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 21, 2024BlackRock, Inc.13GOld format–New–SEC
Mar 29, 2024Ra Capital Management, L.P.13GOld format–New–SEC
Feb 9, 2024Falcon Edge Capital, LP13GOld format–New–SEC
Feb 7, 2024Point72 Asset Management, L.P.13GOld format–New–SEC

Form 144: proposed insider sales

2 notices from officers, directors and other affiliates planning to sell Alto Neuroscience, Inc. shares, newest first.

Form 144 notices for ANRO
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Nov 16, 20264:45 PM ETMichael HanleyOfficer75.0K$2.22MNov 16, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Sep 29, 20264:23 PM ETNicholas SmithOfficer134.9K$3.60MSep 29, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC